Non-chemotherapy drug-induced agranulocytosis (Q34579237)

3 August 2017

1 reference

title

Non-chemotherapy drug-induced agranulocytosis (English)

1 reference

3 August 2017

1 reference

Edeltraut Garbe

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Expert Opinion on Drug Safety

3 August 2017

published in

1 reference

3 August 2017

volume

6

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

323-335

1 reference

Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Drug-induced Blood Dyscrasias in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Neutropenia and agranulocytosis in England and Wales: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Population-based drug-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Incidence of agranulocytosis in Southwest France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Drug-induced myelosuppression : diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Treatment of drug-induced agranulocytosis with haematopoietic growth factors: a review of the clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Idiosyncratic drug-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Drug-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Idiosyncratic drug-induced agranulocytosis: Update of an old disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Risk of clinical blood dyscrasia in a cohort of antibiotic users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Drug-induced immunological neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Drug-Induced Agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

HLA-A2 and B35 are strong predictors of responsiveness to clozapine: preliminary data in Italian schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Treatment of drug-induced agranulocytosis with recombinant GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Filgrastim (r-metHuG-CSF) reversal of drug-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

First use of G-CSF in chlorpromazine-induced agranulocytosis: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

Nonchemotherapy drug-induced agranulocytosis: a review of 118 patients treated with colony-stimulating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

In VitroImmunoreactivity to Propylthiouracil, Methimazole, and Carbimazole in Patients with Graves’ Disease: A Possible Cause of Antithyroid Drug-Induced Agranulocytosis*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.3.323

21 January 2018

Identifiers

DOI

10.1517/14740338.6.3.323

1 reference

3 August 2017

1 reference